The invention concerns a compound of the formula (I)
wherein Ring A is heterocyclyl; m is 0-4 and each R
1
is a group such as hydroxy, halo, trifluoromethyl and cyano; R
2
is halo and n is 0-2; and each R
4
is a group such as hydroxy, halo, trifluoromethyl and cyano; p is 0-4; and R
3
is amino or hydroxy;
or pharmaceutically-acceptable salts or in-vivo-hydrolysable ester or amide thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical condions mediated by histone deacetylase.
本发明涉及一种化合物的公式(I),其中环A是杂环基;m为0-4,每个R1是羟基、卤素、三
氟甲基和
氰基等基团;R2为卤素,n为0-2;每个R4是羟基、卤素、三
氟甲基和
氰基等基团;p为0-4;R3为
氨基或羟基;或其药学上可接受的盐或体内
水解
酯或
酰胺;制备它们的过程,含有它们的制药组合物以及它们在治疗组织
脱乙
酰化酶介导的疾病或医学状况中的使用。